A study investigating its anti-obesity potential in 3T3-L1 adipocytes showed that harpagoside inhibited tumor necrosis factor-α (TNF-α)-induced adipokine expression by activating of peroxisome proliferator-activated receptor gamma (PPAR-γ) [47]. This evidence concerns the gene PPARG and obesity disorder.